SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001047469-98-010658
Filing Date
1998-03-20
Accepted
1998-03-20 00:00:00
Documents
7
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SC 14D9 SC 14D9 70039
2 EXHIBIT 99.1 EX-99.1 57823
3 EXHIBIT 99.2 EX-99.2 170307
4 EXHIBIT 99.3 EX-99.3 7496
5 EXHIBIT 99.4 EX-99.4 22971
6 EXHIBIT 99.5 EX-99.5 3065
7 EXHIBIT 99.6 EX-99.6 5855
  Complete submission text file 0001047469-98-010658.txt   340315
Mailing Address 2255 B QUEEN STREET EAST SUITE 828 TORONTO ONTARIO A6
Business Address 2255 B QUEEN STREET EAST SUITE 828 TORONTO ONTARIO A6 5198368016
INTERNATIONAL MUREX TECHNOLOGIES CORP (Filed by) CIK: 0000864964 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2255 B QUEEN STREET EAST SUITE 828 TORONTO ONTARIO A6
Business Address 2255 B QUEEN STREET EAST SUITE 828 TORONTO ONTARIO A6 5198368016
INTERNATIONAL MUREX TECHNOLOGIES CORP (Subject) CIK: 0000864964 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-41252 | Film No.: 98569476
SIC: 2835 In Vitro & In Vivo Diagnostic Substances